Indies Pharma Jamaica Limited Sustainability Profile
Indies Pharma Jamaica Limited, often referred to as Indies Pharma, is a prominent player in the pharmaceutical industry, headquartered in Jamaica (JM). Established in 2008, the company has made significant strides in the Caribbean market, focusing on the development, manufacturing, and distribution of high-quality generic medications and healthcare products. With a diverse portfolio that includes prescription medications, over-the-counter drugs, and nutraceuticals, Indies Pharma stands out for its commitment to affordability and accessibility. The company has achieved notable milestones, including regulatory approvals and partnerships that enhance its market presence across the Caribbean and beyond. Recognised for its innovative approach and dedication to quality, Indies Pharma Jamaica Limited continues to solidify its position as a trusted provider of healthcare solutions, contributing to the well-being of communities throughout the region.
DitchCarbon Score
How does Indies Pharma Jamaica Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Indies Pharma Jamaica Limited's score of 17 is lower than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Indies Pharma Jamaica Limited's reported carbon emissions
Indies Pharma Jamaica Limited, headquartered in Jamaica (JM), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company has not established documented reduction targets or climate pledges, which suggests a lack of formal commitments to reducing carbon emissions at this time. It is important to note that Indies Pharma Jamaica Limited is a current subsidiary and may inherit climate-related data and initiatives from its parent organization. However, no specific details regarding such cascaded data or initiatives have been provided. In the context of the pharmaceutical industry, companies are increasingly recognising the importance of sustainability and climate action. While Indies Pharma Jamaica Limited has not yet disclosed its emissions or commitments, the industry as a whole is moving towards greater transparency and accountability in environmental impact.
How Carbon Intensive is Indies Pharma Jamaica Limited's Industry?
How Carbon Intensive is Indies Pharma Jamaica Limited's Location?
Indies Pharma Jamaica Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Indies Pharma Jamaica Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Medical Disposables & Supplies Limited
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.